85 related articles for article (PubMed ID: 9310287)
1. Membrane fusion induced by the HIV type 1 fusion peptide: modulation by factors affecting glycoprotein 41 activity and potential anti-HIV compounds.
Pereira FB; Goñi FM; Nieva JL
AIDS Res Hum Retroviruses; 1997 Sep; 13(14):1203-11. PubMed ID: 9310287
[TBL] [Abstract][Full Text] [Related]
2. A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion.
Pritsker M; Jones P; Blumenthal R; Shai Y
Proc Natl Acad Sci U S A; 1998 Jun; 95(13):7287-92. PubMed ID: 9636141
[TBL] [Abstract][Full Text] [Related]
3. Permeabilization and fusion of uncharged lipid vesicles induced by the HIV-1 fusion peptide adopting an extended conformation: dose and sequence effects.
Pereira FB; Goñi FM; Muga A; Nieva JL
Biophys J; 1997 Oct; 73(4):1977-86. PubMed ID: 9336193
[TBL] [Abstract][Full Text] [Related]
4. A salt bridge between an N-terminal coiled coil of gp41 and an antiviral agent targeted to the gp41 core is important for anti-HIV-1 activity.
Jiang S; Debnath AK
Biochem Biophys Res Commun; 2000 Apr; 270(1):153-7. PubMed ID: 10733920
[TBL] [Abstract][Full Text] [Related]
5. Effect of nonpolar substitutions of the conserved Phe11 in the fusion peptide of HIV-1 gp41 on its function, structure, and organization in membranes.
Pritsker M; Rucker J; Hoffman TL; Doms RW; Shai Y
Biochemistry; 1999 Aug; 38(35):11359-71. PubMed ID: 10471286
[TBL] [Abstract][Full Text] [Related]
6. Liposome destabilization induced by the HIV-1 fusion peptide effect of a single amino acid substitution.
Pereira FB; Goñi FM; Nieva JL
FEBS Lett; 1995 Apr; 362(2):243-6. PubMed ID: 7720880
[TBL] [Abstract][Full Text] [Related]
7. Hexapeptides that interfere with HIV-1 fusion peptide activity in liposomes block GP41-mediated membrane fusion.
Gómara MJ; Lorizate M; Huarte N; Mingarro I; Perez-Payá E; Nieva JL
FEBS Lett; 2006 May; 580(11):2561-6. PubMed ID: 16647705
[TBL] [Abstract][Full Text] [Related]
8. Oligopeptide inhibitors of HIV-induced syncytium formation.
Owens RJ; Tanner CC; Mulligan MJ; Srinivas RV; Compans RW
AIDS Res Hum Retroviruses; 1990 Nov; 6(11):1289-96. PubMed ID: 2078410
[TBL] [Abstract][Full Text] [Related]
9. Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell Fusion. Structure-function study.
Kliger Y; Aharoni A; Rapaport D; Jones P; Blumenthal R; Shai Y
J Biol Chem; 1997 May; 272(21):13496-505. PubMed ID: 9153194
[TBL] [Abstract][Full Text] [Related]
10. Antivirals that target the amino-terminal domain of HIV type 1 glycoprotein 41.
Gordon LM; Waring AJ; Curtain CC; Kirkpatrick A; Leung C; Faull K; Mobley PW
AIDS Res Hum Retroviruses; 1995 Jun; 11(6):677-86. PubMed ID: 7576927
[TBL] [Abstract][Full Text] [Related]
11. Membrane-perturbing domains of HIV type 1 glycoprotein 41.
Mobley PW; Pilpa R; Brown C; Waring AJ; Gordon LM
AIDS Res Hum Retroviruses; 2001 Mar; 17(4):311-27. PubMed ID: 11242518
[TBL] [Abstract][Full Text] [Related]
12. The amino-terminal peptide of HIV-1 gp41 interacts with human serum albumin.
Gordon LM; Curtain CC; McCloyn V; Kirkpatrick A; Mobley PW; Waring AJ
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1145-56. PubMed ID: 8312056
[TBL] [Abstract][Full Text] [Related]
13. Design of a peptide inhibitor that blocks the cell fusion mediated by glycoprotein 41 of human immunodeficiency virus type 1.
Jin BS; Ryu JR; Ahn K; Yu YG
AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1797-804. PubMed ID: 11118065
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of the disulfide-bonded loop/chain reversal region of human immunodeficiency virus type 1 gp41 reveals a critical role in gp120-gp41 association.
Maerz AL; Drummer HE; Wilson KA; Poumbourios P
J Virol; 2001 Jul; 75(14):6635-44. PubMed ID: 11413331
[TBL] [Abstract][Full Text] [Related]
15. A trans-dominant mutation in human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp41 inhibits membrane fusion when expressed in target cells.
Elson HF; Dimitrov DS; Blumenthal R
Mol Membr Biol; 1994; 11(3):165-9. PubMed ID: 7742881
[TBL] [Abstract][Full Text] [Related]
16. Identification of membrane-active regions of the HIV-1 envelope glycoprotein gp41 using a 15-mer gp41-peptide scan.
Moreno MR; Pascual R; Villalaín J
Biochim Biophys Acta; 2004 Feb; 1661(1):97-105. PubMed ID: 14967479
[TBL] [Abstract][Full Text] [Related]
17. Role of the fusion peptide and membrane-proximal domain in HIV-1 envelope glycoprotein-mediated membrane fusion.
Dimitrov AS; Rawat SS; Jiang S; Blumenthal R
Biochemistry; 2003 Dec; 42(48):14150-8. PubMed ID: 14640682
[TBL] [Abstract][Full Text] [Related]
18. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
19. Membrane interface-interacting sequences within the ectodomain of the human immunodeficiency virus type 1 envelope glycoprotein: putative role during viral fusion.
Suárez T; Gallaher WR; Agirre A; Goñi FM; Nieva JL
J Virol; 2000 Sep; 74(17):8038-47. PubMed ID: 10933713
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of a hydrophobic tripeptide on human immunodeficiency virus type 1 (HIV-1)-induced syncytium formation and viral infectivity.
Konopka K; Pretzer E; Düzgünes N
Biochem Biophys Res Commun; 1995 Mar; 208(1):75-81. PubMed ID: 7887968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
